These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells. Suzuki S; Furuhashi M; Tsugeno Y; Umetsu A; Ida Y; Hikage F; Ohguro H; Watanabe M J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329980 [TBL] [Abstract][Full Text] [Related]
8. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Rao PV; Deng PF; Kumar J; Epstein DL Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082 [TBL] [Abstract][Full Text] [Related]
9. Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells. Kaneko Y; Ohta M; Inoue T; Mizuno K; Isobe T; Tanabe S; Tanihara H Sci Rep; 2016 Jan; 6():19640. PubMed ID: 26782355 [TBL] [Abstract][Full Text] [Related]
10. The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey. Nilsson SF; Drecoll E; Lütjen-Drecoll E; Toris CB; Krauss AH; Kharlamb A; Nieves A; Guerra T; Woodward DF Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4042-9. PubMed ID: 16936121 [TBL] [Abstract][Full Text] [Related]
11. Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys. Fuwa M; Toris CB; Fan S; Taniguchi T; Ichikawa M; Odani-Kawabata N; Iwamura R; Yoneda K; Matsugi T; Shams NK; Zhang JZ J Ocul Pharmacol Ther; 2018 Sep; 34(7):531-537. PubMed ID: 29989843 [TBL] [Abstract][Full Text] [Related]
12. The effects of exosomes derived from trabecular meshwork cells on Schlemm's canal endothelial cells. Takahashi E; Saruwatari J; Fujimoto T; Tanoue Y; Fukuda T; Inoue T Sci Rep; 2021 Nov; 11(1):21942. PubMed ID: 34754027 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle. Krauss AH; Wiederholt M; Sturm A; Woodward DF Exp Eye Res; 1997 Mar; 64(3):447-53. PubMed ID: 9196397 [TBL] [Abstract][Full Text] [Related]
14. Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys. Fuwa M; Shimazaki A; Odani-Kawabata N; Kirihara T; Taniguchi T; Iwamura R; Yoneda K; Kato M; Morishima K; Shams NK J Ocul Pharmacol Ther; 2021 May; 37(4):223-229. PubMed ID: 33600237 [No Abstract] [Full Text] [Related]
15. Addition of EP2 agonists to an FP agonist additively and synergistically modulates adipogenesis and the physical properties of 3D 3T3-L1 sphenoids. Ida Y; Watanabe M; Umetsu A; Ohguro H; Hikage F Prostaglandins Leukot Essent Fatty Acids; 2021 Aug; 171():102315. PubMed ID: 34246925 [TBL] [Abstract][Full Text] [Related]
16. Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves' Orbitopathy. Ida Y; Ichioka H; Furuhashi M; Hikage F; Watanabe M; Umetsu A; Ohguro H Cells; 2021 Nov; 10(11):. PubMed ID: 34831419 [TBL] [Abstract][Full Text] [Related]
17. The effect of Rho-associated protein kinase inhibitor on monkey Schlemm's canal endothelial cells. Kameda T; Inoue T; Inatani M; Fujimoto T; Honjo M; Kasaoka N; Inoue-Mochita M; Yoshimura N; Tanihara H Invest Ophthalmol Vis Sci; 2012 May; 53(6):3092-103. PubMed ID: 22491412 [TBL] [Abstract][Full Text] [Related]
18. S1P₂ receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology. Sumida GM; Stamer WD Am J Physiol Cell Physiol; 2011 May; 300(5):C1164-71. PubMed ID: 21289286 [TBL] [Abstract][Full Text] [Related]
19. Involvement of RhoA/Rho-associated kinase signal transduction pathway in dexamethasone-induced alterations in aqueous outflow. Fujimoto T; Inoue T; Kameda T; Kasaoka N; Inoue-Mochita M; Tsuboi N; Tanihara H Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7097-108. PubMed ID: 22969074 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study). Aihara M; Lu F; Kawata H; Tanaka Y; Yamamura K; Odani-Kawabata N; Shams NK J Ocul Pharmacol Ther; 2019 Dec; 35(10):542-550. PubMed ID: 31674861 [No Abstract] [Full Text] [Related] [Next] [New Search]